LSZ

LSZ is chemically related to LSD active at similar dosages, with one of its isomers more potent in rats than d-LSD. LSZ sold on white blotter became commercially available in mid 2013. LSZ is one of a group of ergoloids developed by David Nichols' lab at Purdue in the early 2000s, but there are unconfirmed reports that LSZ was previously available on blotter prior to Nichols' first publication. LSZ has three stereoisomers, one (S,S) is substantially more potent than the other three.

LSZ molecular structure diagram from the DrugsPRO substance library.

Also known as: Lambda, La-ss-az, Diazedine, Diazedine, lambda, la-ss-az

Classification

Chemical: Lysergamide
Psychoactive: Psychedelic
Tag: Research-Chemical

Effects

Creativity Enhancement
Nausea
Pupil Dilation
Spontaneous Tactile Sensations
Stimulation
Mentalphysical Stimulation
Analysis Enhancement
Conceptual Thinking
Delusion
Emotion Enhancement
Immersion Enhancement
Memory Suppression
Bodily Control Enhancement
Tactile Enhancement
Hallucinations
Drifting
Color Shifting
Symmetrical Texture Repetition

Routes of Administration

Oral

Dosage

Heavy: 400 ug
Light: 10 – 100 µg
Common: 100 – 300 µg
Strong: 300 – 400 µg
Threshold: 10 ug

Duration

Onset: 0.33-1 h
Comeup: 0.25-0.5 h
Peak: 3-5 h
Offset: 2-3 h
After Effects: 6-24 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

LSZ